432 related articles for article (PubMed ID: 34007178)
1. Current Advances in the Use of Nanophytomedicine Therapies for Human Cardiovascular Diseases.
Hesari M; Mohammadi P; Khademi F; Shackebaei D; Momtaz S; Moasefi N; Farzaei MH; Abdollahi M
Int J Nanomedicine; 2021; 16():3293-3315. PubMed ID: 34007178
[TBL] [Abstract][Full Text] [Related]
2. Recent Developments in Nanomaterials-Based Drug Delivery and Upgrading Treatment of Cardiovascular Diseases.
Mohamed NA; Marei I; Crovella S; Abou-Saleh H
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163328
[TBL] [Abstract][Full Text] [Related]
3. Herbal Medicine for Cardiovascular Diseases: Efficacy, Mechanisms, and Safety.
Shaito A; Thuan DTB; Phu HT; Nguyen THD; Hasan H; Halabi S; Abdelhady S; Nasrallah GK; Eid AH; Pintus G
Front Pharmacol; 2020; 11():422. PubMed ID: 32317975
[TBL] [Abstract][Full Text] [Related]
4. A Review of Medicinal Plants in Cardiovascular Disorders: Benefits and Risks.
Naveed M; Majeed F; Taleb A; Zubair HM; Shumzaid M; Farooq MA; Baig MMFA; Abbas M; Saeed M; Changxing L
Am J Chin Med; 2020; 48(2):259-286. PubMed ID: 32345058
[TBL] [Abstract][Full Text] [Related]
5. Current Perspective and Mechanistic Insights on Bioactive Plant Secondary Metabolites for the Prevention and Treatment of Cardiovascular Diseases.
Grewal J; Kumar V; Gandhi Y; Rawat H; Singh R; Singh A; Narasimhaji CV; Acharya R; Mishra SK
Cardiovasc Hematol Disord Drug Targets; 2023; 23(3):157-176. PubMed ID: 37921163
[TBL] [Abstract][Full Text] [Related]
6. Nanoformulations of natural products for management of metabolic syndrome.
Taghipour YD; Hajialyani M; Naseri R; Hesari M; Mohammadi P; Stefanucci A; Mollica A; Farzaei MH; Abdollahi M
Int J Nanomedicine; 2019; 14():5303-5321. PubMed ID: 31406461
[TBL] [Abstract][Full Text] [Related]
7. A Novel Promising Frontier for Human Health: The Beneficial Effects of Nutraceuticals in Cardiovascular Diseases.
Carrizzo A; Izzo C; Forte M; Sommella E; Di Pietro P; Venturini E; Ciccarelli M; Galasso G; Rubattu S; Campiglia P; Sciarretta S; Frati G; Vecchione C
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33218062
[TBL] [Abstract][Full Text] [Related]
8. Herbal drugs against cardiovascular disease: traditional medicine and modern development.
Li L; Zhou X; Li N; Sun M; Lv J; Xu Z
Drug Discov Today; 2015 Sep; 20(9):1074-86. PubMed ID: 25956424
[TBL] [Abstract][Full Text] [Related]
9. The Effects of Medicinal Plants and Bioactive Natural Compounds on Homocysteine.
Atazadegan MA; Bagherniya M; Askari G; Tasbandi A; Sahebkar A
Molecules; 2021 May; 26(11):. PubMed ID: 34064073
[TBL] [Abstract][Full Text] [Related]
10. Nanoparticles in the New Era of Cardiovascular Therapeutics: Challenges and Opportunities.
Yang P; Ren J; Yang L
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982284
[TBL] [Abstract][Full Text] [Related]
11. Prevention of Cardiovascular Diseases with Anti-Inflammatory and Anti- Oxidant Nutraceuticals and Herbal Products: An Overview of Pre-Clinical and Clinical Studies.
Jain S; Buttar HS; Chintameneni M; Kaur G
Recent Pat Inflamm Allergy Drug Discov; 2018; 12(2):145-157. PubMed ID: 30109827
[TBL] [Abstract][Full Text] [Related]
12. Recent advances on nanoparticle-based therapies for cardiovascular diseases.
Soumya RS; Raghu KG
J Cardiol; 2023 Jan; 81(1):10-18. PubMed ID: 35210166
[TBL] [Abstract][Full Text] [Related]
13. Improving on Nature: The Role of Nanomedicine in the Development of Clinical Natural Drugs.
Bilia AR; Piazzini V; Guccione C; Risaliti L; Asprea M; Capecchi G; Bergonzi MC
Planta Med; 2017 Mar; 83(5):366-381. PubMed ID: 28178749
[TBL] [Abstract][Full Text] [Related]
14. Natural Substances vs. Approved Drugs in the Treatment of Main Cardiovascular Disorders-Is There a Breakthrough?
Grujić-Milanović J; Rajković J; Milanović S; Jaćević V; Miloradović Z; Nežić L; Novaković R
Antioxidants (Basel); 2023 Dec; 12(12):. PubMed ID: 38136208
[TBL] [Abstract][Full Text] [Related]
15. Traditional herbs: a remedy for cardiovascular disorders.
Rastogi S; Pandey MM; Rawat AK
Phytomedicine; 2016 Oct; 23(11):1082-9. PubMed ID: 26656228
[TBL] [Abstract][Full Text] [Related]
16. Nanophytomedicine Based Novel Therapeutic Strategies in Liver Cancer.
Kumar S; Fayaz F; Pottoo FH; Bajaj S; Manchanda S; Bansal H
Curr Top Med Chem; 2020; 20(22):1999-2024. PubMed ID: 31724500
[TBL] [Abstract][Full Text] [Related]
17. Nanoparticle-Mediated Drug Delivery for the Treatment of Cardiovascular Diseases.
Pala R; Anju VT; Dyavaiah M; Busi S; Nauli SM
Int J Nanomedicine; 2020; 15():3741-3769. PubMed ID: 32547026
[TBL] [Abstract][Full Text] [Related]
18. Nanoparticle Based Treatment for Cardiovascular Diseases.
Gupta P; Garcia E; Sarkar A; Kapoor S; Rafiq K; Chand HS; Jayant RD
Cardiovasc Hematol Disord Drug Targets; 2019; 19(1):33-44. PubMed ID: 29737265
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic Applications of Curcumin Nanoformulations.
Yallapu MM; Nagesh PK; Jaggi M; Chauhan SC
AAPS J; 2015 Nov; 17(6):1341-56. PubMed ID: 26335307
[TBL] [Abstract][Full Text] [Related]
20. Cardioprotective Effects of Nanoparticles in Cardiovascular Diseases: A State-of-the-Art Review.
Iqbal J; Iqbal A; Mukhtar H; Jahangir K; Mashkoor Y; Zeeshan MH; Nadeem A; Ashraf A; Maqbool S; Sadiq SM; Lee KY
Curr Probl Cardiol; 2023 Aug; 48(8):101713. PubMed ID: 36967067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
